Aggrastat

Aggrastat (Tirofiban Hydrochloride Monohydrate) is an intravenous medication used to prevent blood clots. It is commonly prescribed for patients undergoing certain heart procedures. This medication helps maintain blood flow in coronary arteries.

Aggrastat is primarily used to prevent blood clots in patients undergoing percutaneous coronary intervention (PCI), a procedure to open blocked coronary arteries. It is also used in the treatment of acute coronary syndrome, a condition that includes heart attack and unstable angina. The medication works by inhibiting platelet aggregation, which helps to keep blood flowing smoothly through the arteries.

Common effects of Aggrastat may include bleeding, bruising, and injection site reactions. Some patients may experience nausea, headache, or dizziness. These effects are generally mild and temporary, but any severe or persistent symptoms should be reported to a healthcare provider.

Aggrastat should be used with caution in patients with a history of bleeding disorders or recent surgery. It is important to monitor for signs of bleeding while using this medication. Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions.

Aggrastat may interact with other medications that affect blood clotting, such as anticoagulants and antiplatelet drugs. It is important to avoid alcohol while using Aggrastat, as it can increase the risk of bleeding. Always consult a healthcare provider before starting or stopping any medication.